These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1529931)

  • 41. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction.
    Bussmann WD; Löhner J; Kaltenbach M
    Am J Cardiol; 1977 Jan; 39(1):91-6. PubMed ID: 318796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The role of nitrates in therapy of heart failure].
    Strasser RH
    Herz; 1996 Jun; 21 Suppl 1():35-7. PubMed ID: 8767923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Nitrate derivatives and cardiac insufficiency].
    Komajda M; Isnard R; Lechat P
    Arch Mal Coeur Vaiss; 1992 Apr; 85 Spec No 1():29-32. PubMed ID: 1530425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Rubin SA; Chatterjee K; Ports TA; Gelberg HJ; Brundage BH; Parmley WW
    Am J Cardiol; 1979 Nov; 44(6):1183-9. PubMed ID: 495513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nitrate resistance and tolerance: potential limitations in the treatment of congestive heart failure.
    Elkayam U; Mehra A; Shotan A; Ostrzega E
    Am J Cardiol; 1992 Sep; 70(8):98B-104B. PubMed ID: 1529933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term effect of isosorbide dinitrate and nifedipine, singly and in association, in patients with chronic heart failure.
    Jezek V; Jezková J; Michaljanic A; Niederle P; Feuereisl R
    Eur Heart J; 1990 Dec; 11(12):1059-64. PubMed ID: 2292252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Recent findings on nitrates: their action, bioactivation and development of tolerance].
    Münzel T
    Dtsch Med Wochenschr; 2008 Oct; 133(44):2277-82. PubMed ID: 18946854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.
    Lewis BS; Rabinowitz B; Schlesinger Z; Caspi A; Markiewicz W; Rosenfeld T; Sclarovsky S; Ermer W
    Cardiology; 1999; 91(1):1-7. PubMed ID: 10393392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The impact of nitrates and mono-therapy and nitrates combined with angiotensin converting enzyme inhibitors on left ventricular remodeling and exercise capacity in patients after acute myocardial infarction].
    Maciejewicz J; Maziarz A; Celibała R; Wiśniewski M; Wiśniewska M
    Przegl Lek; 2003; 60(2):80-4. PubMed ID: 12939852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
    Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
    Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nitrates in congestive heart failure.
    Herman BM; Charlap S; Frishman WH
    Med Clin North Am; 1989 Mar; 73(2):361-71. PubMed ID: 2645481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of phentolamine by nitrates in patients with congestive heart failure.
    Gould L; Reddy CV; Zen B; Singh BK
    Angiology; 1981 Sep; 32(9):595-600. PubMed ID: 6792952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects and development of tolerance using transdermal nitrates in the treatment of congestive heart failure.
    Sjögren A
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 6():117-20. PubMed ID: 3538775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
    Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinical significance of nitrate tolerance in patients with chronic heart failure.
    Packer M
    Eur Heart J; 1989 May; 10 Suppl A():20-5. PubMed ID: 2663503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of acute heart failure following myocardial infarction: hemodynamic advantages of isosorbide dinitrate over frusemide.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Z Kardiol; 1983; 72 Suppl 3():141-6. PubMed ID: 6666215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
    Mantle JA; Russell RO; Moraski RE; Rackley CE
    Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of isosorbide dinitrate on cardiac output in severe cardiac failure: relation to initial hemodynamics, ventricular volume, and the preload reserve mechanism.
    Lewis BS; Hardoff R; Halon DA
    Clin Cardiol; 1989 Sep; 12(9):514-20. PubMed ID: 2791373
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of Heart Failure with Abnormal Left Ventricular Systolic Function in Older Adults.
    Aronow WS
    Heart Fail Clin; 2017 Jul; 13(3):467-483. PubMed ID: 28602366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.